Blood tests may replace scopes for EoE diagnosis

NCT ID NCT01988285

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study enrolled 800 adults undergoing upper endoscopy to find risk factors and blood markers that could help diagnose and monitor eosinophilic esophagitis (EoE), a chronic allergic condition of the esophagus. Researchers compared people with and without EoE, collecting blood, tissue samples, and questionnaire data. The goal is to validate a risk score and test whether blood markers like eotaxin-3 and IL-13 can reliably identify EoE and track treatment response.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

What this could lead to
If successful, this could lead to simpler, less invasive ways to diagnose and monitor EoE using blood tests instead of repeated endoscopies.
What could go wrong
This is an observational study, not a treatment trial. The biomarkers may not prove accurate enough for routine use, and results may not change current care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EOSINOPHILIC ESOPHAGITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of North Carolina, Chapel Hill

    Chapel Hill, North Carolina, 27599, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.